GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Readytech Holdings RDY.AX · AUD

Information Technology · ASX · 🇦🇺 Australia

Compare

1.27

+2.42%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Readytech Holdings annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In AUD.

FY2025FY2024FY2023FY2022FY2021
RevenueA$121.8mA$113.8mA$103.3mA$78.3mA$50.0m
Operating incomeA$15.0mA$12.3mA$9.3mA$11.0mA$5.6m
Net income−A$16.1mA$5.5mA$5.0mA$8.8mA$2.2m
Free cash flowA$4.0mA$13.7mA$8.1mA$4.4mA$13.4m
Total assetsA$250.4mA$261.4mA$259.3mA$186.0mA$169.6m
Shareholders' equityA$141.5mA$151.2mA$128.3mA$98.2mA$75.1m

Revenue by business

Year to 31 Mar 2025

  • Other Global Generics [Member] A$27.55bn · 722.8%
  • Anti-Infective [Member] A$12.77bn · 335.2%
  • Cardiovascular [Member] A$7.06bn · 185.3%
  • Other PSAI [Member] A$6.78bn · 177.9%
  • Nutraceutical [Member] A$6.43bn · 168.6%
  • Central Nervous System [Member] A$3.72bn · 97.7%
  • Pain Management [Member] A$3.67bn · 96.2%
  • Oncology [Member] A$3.40bn · 89.2%
  • Hematology [Member] A$2.46bn · 64.5%
  • Diabetology [Member] A$2.04bn · 53.5%

Revenue by region

Year to 31 Mar 2025

  • UNITED STATES A$149.35bn · 3918.9%
  • Others Countries Country [Member] A$94.40bn · 2476.9%
  • India Country [Member] A$55.83bn · 1465.0%
  • Russia Country [Member] A$25.96bn · 681.1%

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.